Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

March 18, 2021

Study Completion Date

March 18, 2022

Conditions
Coronary Artery DiseaseMyocardial IschemiaCoronary Disease
Interventions
DEVICE

Zotarolimus-Eluting Stent

Percutaneous coronary intervention using zotarolimus-eluting stent

Trial Locations (20)

Unknown

Gyeongsang National University Changwon Hospital, Changwon

Dankook University Hospital, Cheonan

Konkuk University Medical Center, Chungju

Daegu Catholic University Hospital, Daegu

Keimyung University Dongsan Medical Center, Daegu

Kyungpook National University Hospital, Daegu

Yeungnam University Medical Center, Daegu

Eulji Medical Center, Daejeon

Kongyang Univeristy Hospital, Daejeon

Chonnam National University Hospital, Gwangju

Chosun University Hospital, Gwangju

Wongkwang University Hospital, Iksan

Jeonbuk National University Hospital, Jeonju

Presbyterian Medical Center, Jeonju

Dong-A University Hospital, Pusan

Kosin University Gospel Hospital, Pusan

Paik Hospital, Pusan

Pusan National University Hospital, Pusan

Saint Carollo Hospital, Suncheon

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Chonnam National University Hospital

OTHER

NCT04825886 - Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease | Biotech Hunter | Biotech Hunter